593 related articles for article (PubMed ID: 29027056)
1. Curcumin affords neuroprotection and inhibits α-synuclein aggregation in lipopolysaccharide-induced Parkinson's disease model.
Sharma N; Nehru B
Inflammopharmacology; 2018 Apr; 26(2):349-360. PubMed ID: 29027056
[TBL] [Abstract][Full Text] [Related]
2. Apocyanin, NADPH oxidase inhibitor prevents lipopolysaccharide induced α-synuclein aggregation and ameliorates motor function deficits in rats: Possible role of biochemical and inflammatory alterations.
Sharma N; Kapoor M; Nehru B
Behav Brain Res; 2016 Jan; 296():177-190. PubMed ID: 26367469
[TBL] [Abstract][Full Text] [Related]
3. Curcumin protects dopaminergic neurons against inflammation-mediated damage and improves motor dysfunction induced by single intranigral lipopolysaccharide injection.
Sharma N; Sharma S; Nehru B
Inflammopharmacology; 2017 Jun; 25(3):351-368. PubMed ID: 28409389
[TBL] [Abstract][Full Text] [Related]
4. Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism.
Liu Z; Yu Y; Li X; Ross CA; Smith WW
Pharmacol Res; 2011 May; 63(5):439-44. PubMed ID: 21237271
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra.
Heng Y; Zhang QS; Mu Z; Hu JF; Yuan YH; Chen NH
Toxicol Lett; 2016 Jan; 243():7-21. PubMed ID: 26723869
[TBL] [Abstract][Full Text] [Related]
6. Baicalein attenuates α-synuclein aggregation, inflammasome activation and autophagy in the MPP
Hung KC; Huang HJ; Wang YT; Lin AM
J Ethnopharmacol; 2016 Dec; 194():522-529. PubMed ID: 27742410
[TBL] [Abstract][Full Text] [Related]
7. Apocyanin, a Microglial NADPH Oxidase Inhibitor Prevents Dopaminergic Neuronal Degeneration in Lipopolysaccharide-Induced Parkinson's Disease Model.
Sharma N; Nehru B
Mol Neurobiol; 2016 Jul; 53(5):3326-3337. PubMed ID: 26081143
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the lipopolysaccharide induced model of Parkinson's disease: Role of oxidative stress and neuroinflammation.
Sharma N; Nehru B
Neurochem Int; 2015 Aug; 87():92-105. PubMed ID: 26055970
[TBL] [Abstract][Full Text] [Related]
9. Protective role of apigenin on rotenone induced rat model of Parkinson's disease: Suppression of neuroinflammation and oxidative stress mediated apoptosis.
Anusha C; Sumathi T; Joseph LD
Chem Biol Interact; 2017 May; 269():67-79. PubMed ID: 28389404
[TBL] [Abstract][Full Text] [Related]
10. Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model.
Febbraro F; Andersen KJ; Sanchez-Guajardo V; Tentillier N; Romero-Ramos M
Exp Neurol; 2013 Sep; 247():45-58. PubMed ID: 23531432
[TBL] [Abstract][Full Text] [Related]
11. Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and Neuroinflammation in a Rat Model of Parkinson's Disease.
Jayaraj RL; Beiram R; Azimullah S; Meeran MFN; Ojha SK; Adem A; Jalal FY
Molecules; 2019 Jun; 24(11):. PubMed ID: 31185705
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Novel Formulations of Edaravone and Curcumin in the Mouse Intrastriatal Lipopolysaccharide Model of Parkinson's Disease.
Deng I; Garg S; Zhou XF; Bobrovskaya L
Front Biosci (Schol Ed); 2022 May; 14(2):13. PubMed ID: 35730438
[TBL] [Abstract][Full Text] [Related]
13. Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate.
Mandel S; Maor G; Youdim MB
J Mol Neurosci; 2004; 24(3):401-16. PubMed ID: 15655262
[TBL] [Abstract][Full Text] [Related]
14. Formation and Implications of Alpha-Synuclein Radical in Maneb- and Paraquat-Induced Models of Parkinson's Disease.
Kumar A; Leinisch F; Kadiiska MB; Corbett J; Mason RP
Mol Neurobiol; 2016 Jul; 53(5):2983-2994. PubMed ID: 25952542
[TBL] [Abstract][Full Text] [Related]
15. Gallic Acid Attenuated LPS-Induced Neuroinflammation: Protein Aggregation and Necroptosis.
Liu YL; Hsu CC; Huang HJ; Chang CJ; Sun SH; Lin AM
Mol Neurobiol; 2020 Jan; 57(1):96-104. PubMed ID: 31832973
[TBL] [Abstract][Full Text] [Related]
16. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.
Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Fu S
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267220
[TBL] [Abstract][Full Text] [Related]
17. Pro-inflammatory cytokine-mediated ferroportin down-regulation contributes to the nigral iron accumulation in lipopolysaccharide-induced Parkinsonian models.
Zhang Z; Hou L; Song JL; Song N; Sun YJ; Lin X; Wang XL; Zhang FZ; Ge YL
Neuroscience; 2014 Jan; 257():20-30. PubMed ID: 24183966
[TBL] [Abstract][Full Text] [Related]
18. Biochanin A Protects Against Lipopolysaccharide-Induced Damage of Dopaminergic Neurons Both In Vivo and In Vitro via Inhibition of Microglial Activation.
Wang J; Wu WY; Huang H; Li WZ; Chen HQ; Yin YY
Neurotox Res; 2016 Oct; 30(3):486-98. PubMed ID: 27417698
[TBL] [Abstract][Full Text] [Related]
19. Melatonin prevents dopaminergic cell loss induced by lentiviral vectors expressing A30P mutant alpha-synuclein.
Brito-Armas JM; Baekelandt V; Castro-Hernández JR; González-Hernández T; Rodríguez M; Castro R
Histol Histopathol; 2013 Aug; 28(8):999-1006. PubMed ID: 23444197
[TBL] [Abstract][Full Text] [Related]
20. The influence of preconditioning with low dose of LPS on paraquat-induced neurotoxicity, microglia activation and expression of α-synuclein and synphilin-1 in the dopaminergic system.
Kuter KZ; Śmiałowska M; Ossowska K
Pharmacol Rep; 2022 Feb; 74(1):67-83. PubMed ID: 34762280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
